Test ID: MLBRF
MLH1 Hypermethylation and BRAF Mutation Analyses, Tumor
List Fee 
Provides the Mayo Medical Laboratories list fee for performing the test
$735.50
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test was developed and its performance characteristics determined by Laboratory Medicine and Pathology, Mayo Clinic. This test has not been cleared or approved by the U.S. Food and Drug Administration.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
BRAF Mutation Analysis (V600E)
81210-BRAF (v-raf murine sarcoma viral oncogene homolog B1) (eg, colon cancer), gene analysis, V600E variant
MLH1 Hypermethylation
83898 x 2-Amplification, target, each nucleic acid sequence
83907-Lysis of cells prior to nucleic acid extraction
83909-Separation and identification by high-resolution technique
83912-Interpretation and report
For nonparticipating payers:
83898 x 3-Amplification, target, each nucleic acid sequence
83907-Lysis of cells prior to nucleic acid extraction
83909 x 3-Separation and identification by high-resolution technique
83912-Interpretation and report
External
link
PDF
document
Excel
document
Word
document